Cargando…

Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients

BACKGROUND: Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed. However, the emergence of viral variants that are more infectious than the earlier SARS-CoV-2 strains is concerning. Several of these viral variants have the potential to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carreño, Juan Manuel, Alshammary, Hala, Singh, Gagandeep, Raskin, Ariel, Amanat, Fatima, Amoako, Angela, Gonzalez-Reiche, Ana Silvia, van de Guchte, Adriana, study group, PARIS, Srivastava, Komal, Sordillo, Emilia Mia, Sather, D. Noah, van Bakel, Harm, Krammer, Florian, Simon, Viviana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527879/ https://www.ncbi.nlm.nih.gov/pubmed/34688034 http://dx.doi.org/10.1016/j.ebiom.2021.103626

Ejemplares similares

tRNA abundance, modification and fragmentation in nasopharyngeal swabs as biomarkers for COVID-19 severity
por: Katanski, Christopher D., et al.
Publicado: (2022)

Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants
por: Gonzalez-Reiche, Ana S., et al.
Publicado: (2023)

The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD
por: Amanat, Fatima, et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
por: Amanat, Fatima, et al.
Publicado: (2021)

Positive, again! What to make of “re-positive” SARS-CoV-2 molecular test results
por: Simon, Viviana, et al.
Publicado: (2020)

Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model
por: Tan, Jessica, et al.
Publicado: (2022)

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
por: Carreño, Juan Manuel, et al.
Publicado: (2022)

Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave
por: Hernandez, Matthew M., et al.
Publicado: (2021)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Tcheou, Johnstone, et al.
Publicado: (2021)

SARS-CoV-2 spread across the Colombian-Venezuelan border
por: Paniz-Mondolfi, Alberto, et al.
Publicado: (2020)

2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)

Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin
por: Ballesteros, Nathalia, et al.
Publicado: (2021)

Whole-Genome Sequencing: The Key to Unlocking a Nosocomial Outbreak of Coronavirus Disease 2019 (COVID-19)
por: Gottlieb, Lindsey, et al.
Publicado: (2021)

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
por: Escalera, Alba, et al.
Publicado: (2022)

Introductions and early spread of SARS-CoV-2 in the New York City area
por: Gonzalez-Reiche, Ana S., et al.
Publicado: (2020)

RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City
por: Hernandez, Matthew M., et al.
Publicado: (2022)

Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2021)

Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients
por: Gitman, Melissa R, et al.
Publicado: (2021)

SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
por: Kubale, John, et al.
Publicado: (2022)

A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
por: Hernandez, Matthew M., et al.
Publicado: (2022)

A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
por: Hernandez, Matthew M., et al.
Publicado: (2022)

SARS-CoV-2 in Transit: Characterization of SARS-CoV-2 Genomes From Venezuelan Migrants in Colombia
por: Patiño, Luz H., et al.
Publicado: (2021)

Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2022)

Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
por: Carreño, Juan Manuel, et al.
Publicado: (2023)

Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model
por: Roubidoux, Ericka Kirkpatrick, et al.
Publicado: (2021)

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022)

Phylogenetic landscape of Monkeypox Virus (MPV) during the early outbreak in New York City, 2022
por: Patiño, Luz H., et al.
Publicado: (2023)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus
por: Amanat, Fatima, et al.
Publicado: (2021)

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Krammer, Florian, et al.
Publicado: (2021)

Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
por: Aydillo, Teresa, et al.
Publicado: (2022)

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
por: Aydillo, Teresa, et al.
Publicado: (2020)

Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections
por: Singh, Gagandeep, et al.
Publicado: (2023)

Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients
por: Aleman, Adolfo, et al.
Publicado: (2022)

Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina
por: Olivero, Nadia B., et al.
Publicado: (2022)

Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19
por: Britton, Graham J., et al.
Publicado: (2020)

Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19
por: Britton, Graham J., et al.
Publicado: (2021)

Chromatiblock: scalable whole-genome visualization of structural differences in prokaryotes
por: Sullivan, Mitchell John, et al.
Publicado: (2020)

076 Risk of severe COVID-19 associated with immune-modifying drugs: data from PsoProtect and Global Rheumatology Alliance registries
por: Group, P Study, et al.
Publicado: (2022)

Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
por: Carreño, Juan Manuel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61nd2bd98571a2vtgkmaecpdm7